/Companies

Artin Bioscience

Denver, US · Founded 2021 · Delaware corporation

Find your way into Artin Bioscience

Sign up to see every warm intro you have to Artin Bioscience

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Artin Bioscience team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

DD
David DoyleNamed on SEC filing
EE
Erik EgliteNamed on SEC filing
CM
Charles MagolskeNamed on SEC filing
NV
Norbert VoelkelNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$482.5K disclosed across 1 round · 2023

▶$482.5KraisedMar 2023 · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • David DoyleExecutive Officer, Director
  • Erik EgliteExecutive Officer, Director
  • Charles MagolskeExecutive Officer, Director
  • Norbert VoelkelDirector
Offering amount
$482.5K
Amount sold
$482.5K
Minimum investment
$5K
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Artin Bioscience raised?
Artin Bioscience has disclosed $482.5K raised across 1 round.
Where is Artin Bioscience headquartered?
Artin Bioscience is headquartered in Denver, US.